Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less

AIMS: To compare rates of use and adherence for newer versus older second‐line diabetes drug classes in commercially insured, Medicare Advantage and dual‐eligible (covered by both Medicare and Medicaid) patients. MATERIALS AND METHODS: Longitudinal cohort study using insurance claims data from 1/1/2...

Descripción completa

Detalles Bibliográficos
Autores principales: Flory, James H, Li, Jing, Dawwas, Ghadeer K., Leonard, Charles E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279610/
https://www.ncbi.nlm.nih.gov/pubmed/34277970
http://dx.doi.org/10.1002/edm2.245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279610/
https://www.ncbi.nlm.nih.gov/pubmed/34277970
http://dx.doi.org/10.1002/edm2.245

Ejemplares similares